3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31313387 | JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. | 2019 Nov | 2 |
2 | 26131691 | Methotrexate Is a JAK/STAT Pathway Inhibitor. | 2015 | 4 |
3 | 26312921 | Effect of methotrexate on JAK/STAT pathway activation in myeloproliferative neoplasms. | 2015 Feb 26 | 4 |